Note: Ingredients listed on restricted chemical lists
EC/CAS
205-769-8/150-76-5
Name of the chemical
Mequinol
Concentration
<= 100 %
General Information
Product name
Hydroquinone Monomethyl Ether
CAS No.
150-76-5
1.2.1 Relevant identified uses
Laboratory chemicals, Industrial & for professional use only
Emergency telephone
+91 99921 51495
Icons in SDS
Company Information
company name
BIO-CHEM Chemical
e-mail address of the competent person responsible for the Safety Data Sheet
info@biofinechemical.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H317, H319, H361d, H412
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Warning
Hazard statements
H302 Harmful if swallowed. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H361d Suspected of damaging the unborn child. H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P201 Obtain special instructions before use. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P337 + P313 If eye irritation persists: Get medical advice/ attention.
Supplemental label elements
none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 4), H302 Eye irritation (Category 2), H319 Skin sensitisation (Category 1), H317 Reproductive toxicity (Category 2), H361d Chronic aquatic toxicity (Category 3), H412 For the full text of the H-Statements mentioned in this Section, see Section 16.